These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 19896246)

  • 1. Peptide binding to the HLA-DRB1 supertype: a proteochemometrics analysis.
    Dimitrov I; Garnev P; Flower DR; Doytchinova I
    Eur J Med Chem; 2010 Jan; 45(1):236-43. PubMed ID: 19896246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A predictive method for the evaluation of peptide binding in pocket 1 of HLA-DRB1 via global minimization of energy interactions.
    Androulakis IP; Nayak NN; Ierapetritou MG; Monos DS; Floudas CA
    Proteins; 1997 Sep; 29(1):87-102. PubMed ID: 9294869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the polymorphic residues in HLA-DR molecules in allele-specific binding of peptide ligands.
    Marshall KW; Liu AF; Canales J; Perahia B; Jorgensen B; Gantzos RD; Aguilar B; Devaux B; Rothbard JB
    J Immunol; 1994 May; 152(10):4946-57. PubMed ID: 8176213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of peptide affinity to HLA DRB1*0401.
    Marshall KW; Wilson KJ; Liang J; Woods A; Zaller D; Rothbard JB
    J Immunol; 1995 Jun; 154(11):5927-33. PubMed ID: 7751636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physicochemical explanation of peptide binding to HLA-A*0201 major histocompatibility complex: a three-dimensional quantitative structure-activity relationship study.
    Doytchinova IA; Flower DR
    Proteins; 2002 Aug; 48(3):505-18. PubMed ID: 12112675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rough set-based proteochemometrics modeling of G-protein-coupled receptor-ligand interactions.
    Strömbergsson H; Prusis P; Midelfart H; Lapinsh M; Wikberg JE; Komorowski J
    Proteins; 2006 Apr; 63(1):24-34. PubMed ID: 16435365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Several common HLA-DR types share largely overlapping peptide binding repertoires.
    Southwood S; Sidney J; Kondo A; del Guercio MF; Appella E; Hoffman S; Kubo RT; Chesnut RW; Grey HM; Sette A
    J Immunol; 1998 Apr; 160(7):3363-73. PubMed ID: 9531296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In silico prediction of peptide binding affinity to class I mouse major histocompatibility complexes: a comparative molecular similarity index analysis (CoMSIA) study.
    Hattotuwagama CK; Doytchinova IA; Flower DR
    J Chem Inf Model; 2005; 45(5):1415-23. PubMed ID: 16180918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generalized modeling of enzyme-ligand interactions using proteochemometrics and local protein substructures.
    Strömbergsson H; Kryshtafovych A; Prusis P; Fidelis K; Wikberg JE; Komorowski J; Hvidsten TR
    Proteins; 2006 Nov; 65(3):568-79. PubMed ID: 16948162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligand motifs of HLA-DRB5*0101 and DRB1*1501 molecules delineated from self-peptides.
    Vogt AB; Kropshofer H; Kalbacher H; Kalbus M; Rammensee HG; Coligan JE; Martin R
    J Immunol; 1994 Aug; 153(4):1665-73. PubMed ID: 7519208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA DR4w4-binding motifs illustrate the biochemical basis of degeneracy and specificity in peptide-DR interactions.
    Sette A; Sidney J; Oseroff C; del Guercio MF; Southwood S; Arrhenius T; Powell MF; Colón SM; Gaeta FC; Grey HM
    J Immunol; 1993 Sep; 151(6):3163-70. PubMed ID: 7690794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformational and structural characteristics of peptides binding to HLA-DR molecules.
    Hill CM; Hayball JD; Allison AA; Rothbard JB
    J Immunol; 1991 Jul; 147(1):189-97. PubMed ID: 1711073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible association of non-binding of HSP70 to HLA-DRB1 peptide sequences and protection from rheumatoid arthritis.
    Maier JT; Haug M; Föll JL; Beck H; Kalbacher H; Rammensee HG; Dannecker GE
    Immunogenetics; 2002 May; 54(2):67-73. PubMed ID: 12037598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting the binding affinity of epitope-peptides with HLA-A*0201 by encoding atom-pair non-covalent interaction information between receptor and ligands.
    Hu L; Ai Z; Liu P; Xiong Q; Min M; Lan C; Wang J; Fan L; Chen D
    Chem Biol Drug Des; 2010 Jun; 75(6):597-606. PubMed ID: 20565476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of peptide-protein binding using amino acid descriptors: prediction and experimental verification for human histocompatibility complex HLA-A0201.
    Guan P; Doytchinova IA; Walshe VA; Borrow P; Flower DR
    J Med Chem; 2005 Nov; 48(23):7418-25. PubMed ID: 16279801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implication of HLA-DR residues at positions 67, 71, and 86 in interaction between HLA-DR11 and peptide HA306-320.
    Zeliszewski D; Golvano JJ; Gaudebout P; Dorval I; Freidel C; Gebuhrer L; Betuel H; Borras-Cuesta F; Sterkers G
    J Immunol; 1993 Dec; 151(11):6237-47. PubMed ID: 7504016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of naturally processed peptides bound to HLA-DR4, DR53 (DRB1*0405, DRB4*0101)].
    Kinouchi R; Katagiri M
    Hokkaido Igaku Zasshi; 1995 Jan; 70(1):175-81. PubMed ID: 7744365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploration of requirements for peptide binding to HLA DRB1*0101 and DRB1*0401.
    Hill CM; Liu A; Marshall KW; Mayer J; Jorgensen B; Yuan B; Cubbon RM; Nichols EA; Wicker LS; Rothbard JB
    J Immunol; 1994 Mar; 152(6):2890-8. PubMed ID: 8144889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effect of polymorphism at HLA-DR1 beta-chain positions 85 and 86 on binding and recognition of DR1-restricted antigenic peptides.
    Newton-Nash DK; Eckels DD
    J Immunol; 1993 Mar; 150(5):1813-21. PubMed ID: 7679697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naturally processed peptides from rheumatoid arthritis associated and non-associated HLA-DR alleles.
    Kirschmann DA; Duffin KL; Smith CE; Welply JK; Howard SC; Schwartz BD; Woulfe SL
    J Immunol; 1995 Dec; 155(12):5655-62. PubMed ID: 7499850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.